[1]
Süleyman Karaköse et al. 2019. Diagnostic value of the JAK2 V617F mutation for latent chronic myeloproliferative disorders in patients with budd-chiari syndrome and/or portal vein thrombosis. Turkish Journal of Gastroenterology. 26, 1 (Jul. 2019), 42–48.